The Combat Methamphetamine Epidemic Act of 2005 (CMEA) is federal legislation enacted in the United States on March 9, 2006, to regulate, among other things, retail over-the-counter sales of following products because of their use in the manufacture of illegal drugs: Retail provisions of the CMEA include daily sales limits and 30-day purchase limits, placement of product out of direct customer access, sales logbooks, customer ID verification, employee training, and self-certification of regulated sellers.

The CMEA is found as Title VII of the USA PATRIOT Improvement and Reauthorization Act of 2005 (H.R.

The U.S. Department of Justice claimed that states that had enacted similar or more restrictive retail regulations saw dramatic drops in the numbers of small clandestine labs.

[1] "The CMEA requires record-keeping and identification of all sales and reports to law enforcement of any 'suspicious' transactions.

Naveau had gone over the legal limit for pseudoephedrine when he purchased extra Claritin-D to give to his son before he attended church camp.